Aprecia Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Aprecia Pharmaceuticals's estimated annual revenue is currently $12.9M per year.
- Aprecia Pharmaceuticals's estimated revenue per employee is $170,000
- Aprecia Pharmaceuticals's total funding is $158.4M.
Employee Data
- Aprecia Pharmaceuticals has 76 Employees.
- Aprecia Pharmaceuticals grew their employee count by 41% last year.
Aprecia Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Pharmaceutical Development | Reveal Email/Phone |
2 | VP Pharmaceutical Development | Reveal Email/Phone |
3 | VP Operations | Reveal Email/Phone |
4 | SVP, Business Operations & CFO | Reveal Email/Phone |
5 | SVP, Regulatory Affairs | Reveal Email/Phone |
6 | VP Medical and Clinical Affairs | Reveal Email/Phone |
7 | VP Quality Assurance | Reveal Email/Phone |
8 | VP, Business Development & Alliance Management | Reveal Email/Phone |
9 | Senior Director Quality Control and Analytical Development | Reveal Email/Phone |
10 | President & Chief Operating Officer | Reveal Email/Phone |
Aprecia Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.9M | 76 | 41% | $158.4M | N/A |
#2 | $142.9M | 662 | 14% | $1.4M | N/A |
#3 | $1M | 10 | 0% | N/A | N/A |
#4 | $20.7M | 122 | -8% | $28.7M | N/A |
#5 | $54.8M | 293 | -14% | N/A | N/A |
#6 | $8.4M | 55 | 10% | N/A | N/A |
What Is Aprecia Pharmaceuticals?
Aprecia, The 3DP Pharmaceutical Company, expects to use its ZipDose® Technology to transform the way people take medicine. Its first innovation, ZipDose Technology can be combined with a wide variety of active pharmaceutical ingredients to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. Aprecia is committed to enhancing the patient experience through novel approaches to drug delivery that address unmet treatment needs to eliminate patient suffering and caregiver burden.
keywords:N/A
$158.4M
Total Funding
76
Number of Employees
$12.9M
Revenue (est)
41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aprecia Pharmaceuticals News
D., as Vice President of Pharmaceutical Development. Gosselin will oversee product development from early innovation to commercial production at...
Currently, there is only one 3D printed drug approved by the FDA, Aprecia Pharmaceuticals' Spritam, which is used in the treatment of...
WEST LAFAYETTE, Ind. and CINCINNATI, Nov. 18, 2020 /PRNewswire/ -- Purdue University continues to make giant leaps in innovation with the recent 3D printing (3DP) equipment donation from its industry partner Aprecia Pharmaceuticals. The donated equipment will enable research across multiple si ...
Aprecia Pharmaceuticals Company, a Langhorne, PA-based commercial stage pharmaceutical company, entered into an up to $30 million debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC). The company received initial funding of $20m under the debt financing agreement has the option to ...
Aprecia Pharmaceuticals Company (Aprecia), a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, today announced that it has entered into an up to $30 million debt financing agreement with Hercules Capital, Inc.. Ap ...
Other Companies in Blue Ash
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $22.3M | 77 | 15% | N/A |
#2 | $15M | 84 | 8% | N/A |
#3 | $15.3M | 94 | 4% | N/A |
#4 | $21.4M | 102 | 6% | N/A |
#5 | $75M | 114 | 58% | N/A |